Physician profile
Matthew Eckermann
NPI 1679543474
$2,838.33
in general payments reported to CMS, 2019-2025
30 companies · $301 in 2025
The $301 reported for 2025 was more than what 87% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,313 · 2020: $176 · 2021: $616 · 2022: $207 · 2023: $182 · 2024: $43.11 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $526.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $960.62 | 2019 | |
| Si-Bone, INC. | $280.99 | 2019-2023 | |
| Boston Scientific Corporation | $161.29 | 2020-2025 | Wavewriter Alpha Prime 16 |
| Arthrex, INC. | $156.76 | 2025 | |
| Avanos Medical | $155.47 | 2021-2022 | |
| Medtronic USA, INC. | $136.70 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $95.35 | 2021 | |
| Lilly USA, LLC | $92.08 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $82.94 | 2020-2021 | |
| Abbvie INC. | $80.60 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $61.73 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $59.08 | 2019-2024 | Iovera, Exparel |
| Vertos Medical, INC. | $55.95 | 2021 | |
| Collegium Pharmaceutical, INC. | $54.85 | 2019-2022 | |
| Horizon Therapeutics Plc | $43.18 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $40.99 | 2021 | |
| Lundbeck LLC | $37.09 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.96 | 2019-2021 | |
| Ibsa Pharma INC. | $30.41 | 2021-2022 | |
| Gemini Mountain Medical, LLC | $27.79 | 2025 | |
| Medtronic, INC. | $26.43 | 2021 | |
| Nevro Corp. | $23.54 | 2020 | |
| Abbott Laboratories | $23.40 | 2022 | |
| Amgen INC. | $20.09 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $20.08 | 2020 | |
| Bioventus LLC | $18.83 | 2022 | |
| Kci USA, INC. | $18.41 | 2023 | Prevena, V.A.C.Ulta |
| Arbor Pharmaceuticals, INC. | $16.79 | 2019 | |
| Relievant Medsystems, INC. | $14.92 | 2021 | |
| Pfizer INC. | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Eckermann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.